General Information of the Compound
| Compound ID |
CP0288393
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-(4-methylpiperazin-1-yl)phenyl]quinolin-4-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1NCZHO
AKOS024359777
BDBM50196110
CHEMBL217665
ChemDiv1_019259
GNF-PF-2857
HMS641L09
MCULE-1778420008
N-(4-(4-methylpiperazin-1-yl)phenyl)quinolin-4-amine
N-[4-(4-methylpiperazin-1-yl)phenyl]quinolin-4-amine
Oprea1_484208
SCHEMBL7129284
SR-01000394477
SR-01000394477-1
ST50989409
ZINC1507915
[4-(4-methylpiperazinyl)phenyl]-4-quinolylamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H22N4
|
||||||||||||||||||
| Molecular Weight |
318.424
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN(CC1)c1ccc(Nc2ccnc3ccccc23)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H22N4/c1-23-12-14-24(15-13-23)17-8-6-16(7-9-17)22-20-10-11-21-19-5-3-2-4-18(19)20/h2-11H,12-15H2,1H3,(H,21,22)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RXXDJBWYJTWSKV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01650, Alpha-2A adrenergic receptor
Protein ID: PT02026, Alpha-2B adrenergic receptor
Protein ID: PT01598, Alpha-2C adrenergic receptor
Clinical Information about the Compound